Health In Tech, Inc. (Nasdaq: HIT) announced its unaudited financial results for the third quarter ended September 30, 2026. The company reported Q3 2026 revenue of $6.6 million, a decrease compared to $8.5 million in the same period in 2025. For the first nine months of 2026, total revenue was $23.4 million, down from $25.8 million in the prior year period.

During the third quarter, the company recorded a net loss of $7.1 million, or $(0.11) per diluted share. This compares to net income of $0.5 million, or $0.01 per diluted share, in Q3 2025. For the first nine months of 2026, the net loss was $11.2 million, or $(0.18) per diluted share, compared to net income of $1.6 million, or $0.03 per diluted share, for the first nine months of 2025. The net loss for Q3 included a provision for credit losses of $5.3 million.

On an adjusted basis, the company reported an Adjusted EBITDA loss of $(3.9) million for Q3 2026 and a loss of $(6.6) million for the first nine months of 2026. As of September 30, 2026, the company had a cash balance of $10.1 million.

Health In Tech highlighted growth in its distribution network, which reached 984 partners as of September 30, 2026, representing a 15.9% increase year over year. The company also reported contracted revenue of $32.7 million for the first nine months of 2026, with $24.4 million recognized as GAAP revenue. The remaining $8.3 million is expected to be recognized in future periods, with $6.1 million anticipated in Q4 2026 and $2.2 million in 2027.

As of October 30, 2026, the company reported pipeline revenue of $156.4 million. The company also noted Platform Placed Plan Value (PPPV) of $91.8 million as of September 30, 2026.

In other business developments, Health In Tech launched HitRix in September 2026, an AI-powered marketplace for large-group self-funded stop-loss insurance. The company also advanced its Three-Year Rate Stabilization Program, securing its first client. Additionally, the company announced a leadership transition, appointing Sanjay Shrestha as Chief Executive Officer effective October 20, 2026, with founder Tim Johnson transitioning to Executive Chairman. The company also elected Tim Cortes as an independent director at its November 10, 2026 Annual Meeting of Stockholders.

Health In Tech revised its full-year 2026 revenue outlook to approximately $30 million, which is modestly below 2025 revenue. The revision is attributed to a delayed commencement of certain new policies resulting from a transition to a new carrier, which temporarily extended underwriting and onboarding timelines.